tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
SynAct Pharma Publishes 2025 Annual Results and Highlights R&D Focus
PremiumCompany AnnouncementsSynAct Pharma Publishes 2025 Annual Results and Highlights R&D Focus
1M ago
SynAct Pharma Advances SEK 5 Million Share Buyback, Reacquires 212,307 Shares
Premium
Company Announcements
SynAct Pharma Advances SEK 5 Million Share Buyback, Reacquires 212,307 Shares
1M ago
SynAct Pharma Plans Capital Markets Day Ahead of Key Clinical Readouts
Premium
Company Announcements
SynAct Pharma Plans Capital Markets Day Ahead of Key Clinical Readouts
1M ago
SynAct Pharma Leadership Enters Lock-Up Ahead of Key Clinical Milestones
PremiumCompany AnnouncementsSynAct Pharma Leadership Enters Lock-Up Ahead of Key Clinical Milestones
3M ago
SynAct Pharma Leadership Buys Shares as Key Rheumatoid Arthritis Milestone Nears
Premium
Company Announcements
SynAct Pharma Leadership Buys Shares as Key Rheumatoid Arthritis Milestone Nears
3M ago
SynAct Pharma AB Appoints Nomination Committee for 2026 AGM
Premium
Company Announcements
SynAct Pharma AB Appoints Nomination Committee for 2026 AGM
3M ago
SynAct Pharma to Engage in Strategic Discussions at BioEurope 2025
PremiumCompany AnnouncementsSynAct Pharma to Engage in Strategic Discussions at BioEurope 2025
5M ago
SynAct Pharma’s Q3 2025 Interim Report Highlights
Premium
Company Announcements
SynAct Pharma’s Q3 2025 Interim Report Highlights
5M ago
SynAct Pharma AB Announces Extraordinary General Meeting to Discuss Key Resolutions
Premium
Company Announcements
SynAct Pharma AB Announces Extraordinary General Meeting to Discuss Key Resolutions
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100